Stefan Sjöberg

Publications
CV
Public outreach and news

Articles

Article: HELIYON. 2024;10(8):e29498
Mixed methods study on the feasibility of implementing periodic continuous glucose monitoring among individuals with type 2 diabetes mellitus in a primary care setting
Johansson U-B; Gleissman SA; Liden MK; Wickman M; Gustafsson B; Sjoberg S
Article: JOURNAL OF NEUROENDOCRINOLOGY. 2023;35(5):e13272
Higher CSF/serum free-T4 ratio is associated with improvement of quality of life during treatment with L-thyroxine
Funkquist A; Wandt B; Blennow K; Zetterberg H; Svensson J; Bjellerup P; Freund-Levi Y; Sjoberg S
Journal article: JOURNAL OF MEDICAL ECONOMICS. 2020;23(11):1311-1320
Real-world cost-effectiveness of insulin degludec in type 1 and type 2 diabetes mellitus from a Swedish 1-year and long-term perspective
Jendle J; Ericsson A; Ekman B; Sjoberg S; Gundgaard J; da Rocha Fernandes J; Mardby A-C; Hunt B; Malkin SJP; Thunander M
Article: JOURNAL OF CLINICAL & TRANSLATIONAL ENDOCRINOLOGY. 2020;19:100218
Low CSF/serum ratio of free T4 is associated with decreased quality of life in mild hypothyroidism - A pilot study
Funkquist A; Bengtsson A; Johansson PM; Svensson J; Bjellerup P; Blennow K; Wandt B; Sjoberg S
Article: DIABETES THERAPY. 2019;10(6):2115-2130
Effect of Liraglutide on Times in Glycaemic Ranges as Assessed by CGM for Type 2 Diabetes Patients Treated With Multiple Daily Insulin Injections
Sofizadeh S; Imberg H; Olafsdottir AF; Ekelund M; Dahlqvist S; Hirsch I; Filipsson K; Ahren B; Sjoberg S; Tuomilehto J; Lind M
Journal article: VALUE IN HEALTH. 2019;22:s575-s576
PDB23 SWITCHING TO INSULIN DEGLUDEC IS A COST-SAVING THERAPY FOR PATIENTS WITH TYPE 1 AND TYPE 2 DIABETES IN THE SWEDISH SETTING BASED ON REAL WORLD DATA
Jendle J; Thunander M; Ekman B; Sjöberg S; Ericsson Å; da Rocha Fernandes J; Mårdby AC; Malkin SJP; Hunt B
Article: OBESITY SCIENCE & PRACTICE. 2019;5(2):130-140
Effect of liraglutide on anthropometric measurements, sagittal abdominal diameter and adiponectin levels in people with type 2 diabetes treated with multiple daily insulin injections: evaluations from a randomized trial (MDI-liraglutide study 5)
Ahmadi SS; Filipsson K; Dimenaes H; Isaksson SS; Imberg H; Sjoeberg S; Ahren B; Dahlqvist S; Gustafsson T; Tuomilehto J; Hirsch IB; Lind M
Article: THE BMJ. 2015;351:h5364
Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial)
Lind M; Hirsch IB; Tuomilehto J; Dahlqvist S; Ahren B; Torffvit O; Attvall S; Ekelund M; Filipsson K; Tengmark B-O; Sjoberg S; Pehrsson N-G
Article: JOURNAL OF LIPID RESEARCH. 2014;55(11):2408-2415
Thyroid hormone reduces PCSK9 and stimulates bile acid synthesis in humans
Bonde Y; Breuer O; Luetjohann D; Sjoberg S; Angelin B; Rudling M
Article: EUROPEAN ENDOCRINOLOGY. 2013;9(1):37-39
Short-term Withdrawal of Levothyroxine, Induced Increase of Thyroid-stimulating Hormone and an Increase Ratio of Triiodothyronine to Thyroxine.
Carlwe M; Schaffer T; Sjöberg S
Article: SCANDINAVIAN JOURNAL OF CLINICAL AND LABORATORY INVESTIGATION. 2011;71(1):63-67
L-thyroxine treatment in primary hypothyroidism does not increase the content of free triiodothyronine in cerebrospinal fluid: A pilot study
Sjoberg S; Eriksson M; Werner S; Bjellerup P; Nordin C
Article: AMERICAN JOURNAL OF PHYSIOLOGY - ENDOCRINOLOGY AND METABOLISM. 2007;292(3):E709-E714
Lactate release from adipose tissue and skeletal muscle in vivo: defective insulin regulation in insulin-resistant obese women
Qvisth V; Hagstrom-Toft E; Sjoberg MS; Bolinder J
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM (JCEM). 2004;89(9):4693-4700
Combined hyperinsulinemia and hyperglycemia, but not hyperinsulinemia alone, suppress human skeletal muscle lipolytic activity in vivo
Qvisth V; Hagström-Toft E; Enoksson S; Sherwin RS; Sjöberg S; Bolinder J
Article: APPETITE. 2003;41(2):213-214
Changes in cerebrospinal fluid signalling substances and appetite scores following 48 h fast in healthy volunteers
Arner P; Sjöberg S; Nordin C; Eriksson M
Article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2003;13(5):333-335
CSF taurine level is influenced by plasma cholesterol and the CYP2D6 phenotype
Nordin C; Dahl ML; Eklundh T; Eriksson M; Sjöberg S
Journal article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2003;23(2):461-467
Introductory experiments on ligand liposomes as delivery agents for boron neutron capture therapy.
Bohl Kullberg E; Carlsson J; Edwards K; Capala J; Sjöberg S; Gedda L
Journal article: JOURNAL OF ORGANOMETALLIC CHEMISTRY. 2003;680(1-2):188-192
High yield [125I]iodide-labeling of iodinated carboranes by palladium-catalyzed isotopic exchange
Winberg KJ; Barberà G; Eriksson L; Teixidor F; Tolmachev V; Viñas C; Sjöberg S
Journal article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2002;12:410-411
CSF taurine level is influenced by plasma cholesterol and the CYP2D6 phenotype
Nordin C; Dahl ML; Eklundh T; Eriksson M; Sjöberg S
Article: JOURNAL OF INTERNAL MEDICINE. 2002;252(4):342-351
Residual insulin secretion is not coupled to a maintained glucagon response to hypoglycaemia in long-term type 1 diabetes
Sjöberg S; Ahrén B; Bolinder J
Article: AMERICAN JOURNAL OF PHYSIOLOGY - ENDOCRINOLOGY AND METABOLISM. 2002;283(2):E295-E301
No apparent suppression by insulin of in vivo skeletal muscle lipolysis in nonobese women
Moberg E; Sjöberg S; Hagström-Toft E; Bolinder J
Journal article: RADIOCHIMICA ACTA. 2002;90(4):229-235
Radiobromination of closo-dodecaborate anion. Aspects of labelling chemistry in aqueous solution using Chloramine-T
Tolmachev V; Bruskin A; Sivaev I; Lundqvist H; Sjöberg S
Journal article: COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS. 2002;67(7):913-935
Polyhedral Boron Compounds as Potential Linkers for Attachment of Radiohalogens to Targeting Proteins and Peptides. A Review
Tolmachev V; Sjöberg S
Journal article: COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS. 2002;67(6):679-727
Chemistry of closo-Dodecaborate Anion [B12H12]2-: A Review
Sivaev IB; Bregadze VI; Sjöberg S
Article: ANNALS OF EMERGENCY MEDICINE. 2001;37(6):561-567
Frequent use of the hospital emergency department is indicative of high use of other health care services
Hansagi H; Olsson M; Sjöberg S; Tomson Y; Göransson S
Journal article: JOURNAL OF LABELLED COMPOUNDS AND RADIOPHARMACEUTICALS. 2001;44(S1):s962-s964
Bromination of closo‐dodecaborate (2‐) anion in aqueous media using chloramine‐T
Tolmachev V; Sjöberg S; Lundqvist H
Article: NEUROPSYCHOBIOLOGY. 2001;43(2):70-74
Depressive symptoms in hypothyroid disorder with some observations on biochemical correlates
Gunnarsson T; Sjöberg S; Eriksson M; Nordin C
Article: NEUROPSYCHOBIOLOGY. 2001;43(1):19-22
CSF collection time at lumbar puncture is influenced by plasma cholesterol and triglycerides
Nordin C; Eklundh T; Eriksson M; Sjöberg S
Article: JOURNAL OF NEURAL TRANSMISSION. 1999;106(3-4):275-282
Cholecystokinin peptides in cerebrospinal fluid:: a study in healthy male subjects lumbar-punctured without preceding strict bed-rest
Gunnarsson T; Eklundh T; Eriksson M; Sjöberg S; Nordin C
Article: HUMAN PSYCHOPHARMACOLOGY. 1999;14(2):113-117
Cholecystokinin peptides in cerebrospinal fluid:: a pilot study in hypothyroid patients
Gunnarsson T; Sjöberg S; Eriksson M; Nordin C
Journal article: HUMAN PSYCHOPHARMACOLOGY. 1999;14(2):113-117
Cholecystokinin peptides in cerebrospinal fluid: a pilot study in hypothyroid patients
Gunnarsson T; Sjöberg S; Eriksson M; Nordin C
Article: LAKARTIDNINGEN. 1998;95(47):5320-5324
[A survey of "heavy consumers" of emergency care services in Stockholm. Six per cent of the patients accounted for a quarter of emergency consultations].
Hansagi H; Olsson M; Sjöberg S
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY (EJE). 1998;139(5):493-497
L-thyroxine treatment and neurotransmitter levels in the cerebrospinal fluid of hypothyroid patients:: a pilot study
Sjöberg S; Eriksson M; Nordin C
Journal article: TETRAHEDRON LETTERS. 1998;39(18):2813-2814
An enantioselective synthesis of (+)-pseudohygroline
Enierga G; Hockless DCR; Perlmutter P; Rose M; Sjöberg S; Wong K
Journal article: TETRAHEDRON. 1998;54(15):3877-3884
Synthesis of novel boronated acridines- and spermidines as possible agents for BNCT
Ghaneolhosseini H; Tjarks W; Sjöberg S
Journal article: RUSSIAN CHEMICAL BULLETIN. 1998;47(1):193-194
A mild synthesis of the [B12H11CO]− anion
Sivaev IB; Bregadze VI; Sjöberg S
Article: THE LANCET. 1997;350(9070):29-30
Is the cholesterol-lowering effect of simvastatin influenced by CYP2D6 polymorphism?
Nordin C; Dahl ML; Eriksson M; Sjoberg S
Article: REGULATORY PEPTIDES. 1997;68(1):57-61
Cholecystokinin peptides in cerebrospinal fluid: A study in healthy male subjects
Gunnarsson T; Eklundh T; Eriksson M; Qureshi GA; Sjoberg S; Nordin C
Journal article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 1996;6:s4-160
P.6.014 Cholecystokinin peptides in cerebrospinal fluid: Findings in healthy male volunteers
Gunnarsson T; Eklundh T; Eriksson M; Sjöberg S; Nordin C
Article: BIOLOGICAL PSYCHIATRY. 1996;40(4):302-304
Cholesterol lowering and cerebrospinal fluid neurotransmitters: Increased levels of the anxiogenic cholecystokinin-tetrapeptide during simvastatin administration to healthy male volunteers
Eriksson M; Eklundh T; Sjoberg S; Angelin B; Nordin C
Article: DIABETOLOGIA. 1996;39(7):845-853
Stimulation of adipose tissue lipolysis following insulin-induced hypoglycaemia: Evidence of increased beta-adrenoceptor-mediated lipolytic response in IDDM
Bolinder J; Sjoberg S; Arner P
Journal article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 1996;6:113
P-10-18 CCK-4 in cerebrospinal fluid: A pilot study in healthy male volunteers
Gunnarsson T; Eklundh T; Eriksson M; Nordin C; Sjöberg S
Article: JOURNAL OF PSYCHIATRIC RESEARCH. 1996;30(3):201-208
Monoamine precursors, transmitters and metabolites in cerebrospinal fluid: A prospective study in healthy male subjects
Eklundh T; Eriksson M; Sjoberg S; Nordin C
Journal article: EUROPEAN PSYCHIATRY. 1996;11:339s
Monoamine precursors, transmitters and metabolites in cerebrospinal fluid: A study in healthy male subjects
Eklundh T; Eriksson M; Sjöberg S; Nordin C
Journal article: JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM (JCEM). 1993;77(4):976-981
INFLUENCE OF COMBINED C-PEPTIDE AND INSULIN ADMINISTRATION ON RENAL-FUNCTION AND METABOLIC CONTROL IN DIABETES TYPE-1
JOHANSSON BL; KERNELL A; SJOBERG S; WAHREN J
Journal article: JOURNAL OF DIABETES AND ITS COMPLICATIONS. 1992;6(2):89-95
von Willebrand factor antigen in plasma and urine in patients with type I (insulin-dependent) diabetes mellitus with and without nephropathy.
Silveira AM; Sjöberg S; Blombäck M; Ostman J
Journal article: DIABETOLOGIA. 1992;35(2):121-128
THE INFLUENCE OF HUMAN C-PEPTIDE ON RENAL-FUNCTION AND GLUCOSE-UTILIZATION IN TYPE-1 (INSULIN-DEPENDENT) DIABETIC-PATIENTS
JOHANSSON BL; SJOBERG S; WAHREN J
Journal article: DIABETES, NUTRITION AND METABOLISM - CLINICAL AND EXPERIMENTAL. 1992;5(4):259-264
HIGH-DIETARY FIBER INTAKE DOES NOT REDUCE THE BIOAVAILABILITY OF GLIBENCLAMIDE (HB-420) IN TYPE-II (NON-INSULIN-DEPENDENT) DIABETES-MELLITUS
OSTMAN J; SJOBERG S; THUNBERG E; GUNNARSSON R; FAXEN G; CHRISTENSON I
Journal article: DIABETOLOGIA. 1991;34(6):423-428
RENAL AND SPLANCHNIC EXCHANGE OF HUMAN BIOSYNTHETIC C-PEPTIDE IN TYPE-1 (INSULIN-DEPENDENT) DIABETES-MELLITUS
SJOBERG S; JOHANSSON BL; OSTMAN J; WAHREN J
Journal article: JOURNAL OF DIABETIC COMPLICATIONS. 1991;5(1):18-22
Residual C-peptide excretion is associated with a better long-term glycemic control and slower progress of retinopathy in type I (insulin-dependent) diabetes mellitus.
Sjöberg S; Gjötterberg M; Berglund L; Möller E; Ostman J
Journal article: DIABETOLOGIA. 1989;32(10):753-758
CIRCULATING INSULIN-LIKE GROWTH FACTOR-I IN TYPE-1 (INSULIN-DEPENDENT) DIABETIC-PATIENTS WITH RETINOPATHY
ARNER P; SJOBERG S; GJOTTERBERG M; SKOTTNER A
Journal article: DIABETIC MEDICINE. 1988;5(5):449-453
HEALTH ATTITUDES, SELF-MONITORING OF BLOOD-GLUCOSE, METABOLIC CONTROL AND RESIDUAL INSULIN-SECRETION IN TYPE-1 DIABETIC-PATIENTS
SJOBERG S; CARLSON A; ROSENQVIST U; OSTMAN J
Journal article: DIABETIC MEDICINE. 1987;4(3):245-247
LACK OF PHARMACOKINETIC INTERACTION BETWEEN GLIBENCLAMIDE AND TRIMETHOPRIM-SULFAMETHOXAZOLE
SJOBERG S; WIHOLM BE; GUNNARSSON R; EMILSSON H; THUNBERG E; CHRISTENSON I; OSTMAN J
Journal article: DIABETOLOGIA. 1987;30(4):208-213
RESIDUAL INSULIN PRODUCTION, GLYCEMIC CONTROL AND PREVALENCE OF MICROVASCULAR LESIONS AND POLYNEUROPATHY IN LONG-TERM TYPE-1 (INSULIN-DEPENDENT) DIABETES-MELLITUS
SJOBERG S; GUNNARSSON R; GJOTTERBERG M; LEFVERT AK; PERSSON A; OSTMAN J
Journal article: ACTA MEDICA SCANDINAVICA. 1987;222(5):445-451
SERUM-LIPID AND LIPOPROTEIN LEVELS IN LONG-TERM INSULIN-DEPENDENT DIABETES-MELLITUS - RELATION TO RESIDUAL INSULIN-SECRETION, MICROVASCULAR LESIONS AND ENVIRONMENTAL-FACTORS
SJOBERG S; GUNNARSSON R; ROSSNER S; OSTMAN J
Journal article: JOURNAL OF CHROMATOGRAPHY A. 1986;383(1):93-102
HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF GLIBENCLAMIDE IN HUMAN-PLASMA AND URINE
EMILSSON H; SJOBERG S; SVEDNER M; CHRISTENSON I
Journal article: TRANSPLANTATION PROCEEDINGS. 1986;18(6):1498-1499
SIGNIFICANCE OF RESIDUAL INSULIN PRODUCTION IN LONG-TERM TYPE-I DIABETES-MELLITUS FOR GLUCOSE CONTROL AND PREVALENCE OF MICROANGIOPATHIC LESIONS
SJOBERG S; GJOTTERBERG M; LEFVERT AK; GUNNARSSON R; OSTMAN J
Journal article: ACTA MEDICA SCANDINAVICA. 1983;214(3):231-237
RESIDUAL C-PEPTIDE PRODUCTION IN TYPE-I DIABETES-MELLITUS - A COMPARISON OF DIFFERENT METHODS OF ASSESSMENT AND INFLUENCE ON GLUCOSE CONTROL
SJOBERG S; GUNNARSSON R; OSTMAN J
Journal article: ACTA PAEDIATRICA SCANDINAVICA. 1983;72(1):47-51
RESPIRATORY SYNCYTIAL VIRUS-INFECTION IN YOUNG HOSPITALIZED CHILDREN - IDENTIFICATION OF RISK PATIENTS AND PREVENTION OF NOSOCOMIAL SPREAD BY RAPID DIAGNOSIS
ERIKSSON M; FORSGREN M; SJOBERG S; VONSYDOW M; WOLONTIS S
Show more

All other publications

Conference publication: VALUE IN HEALTH. 2019;22:S575-S576
SWITCHING TO INSULIN DEGLUDEC IS A COST-SAVING THERAPY FOR PATIENTS WITH TYPE 1 AND TYPE 2 DIABETES IN THE SWEDISH SETTING BASED ON REAL WORLD DATA
Jendle J; Thunander M; Ekman B; Sjoberg S; Ericsson A; Fernandes DRJ; Mardby AC; Malkin SJP; Hunt B
Conference publication: DIABETOLOGIA. 2019;62:S436
Real-world cost-effectiveness of insulin degludec in type 1 and type 2 diabetes in a Swedish setting
Jendle JH; Thunander M; Sjoberg S; Ekman B; Mardby A-C; Fernandes JDR; Gundgaard J; Ericsson A
Conference publication: DIABETOLOGIA. 2015;58:S37
A randomised double-blind trial of liraglutide to control HbA_1c in subjects with type 2 diabetes treated with multiple daily insulin injections (MDILiraglutide trial)
Lind M; Hirsch I; Tuomilehto J; Dahlqvist S; Ahren B; Torffvit O; Attvall S; Ekelund M; Filipsson K; Tengmark B-O; Sjoberg S; Pehrsson N-G
Letter: JOURNAL OF INTERNAL MEDICINE. 2005;257(3):313-314
Risk for fatal statin-induced rhabdomyolysis as a consequence of misinterpretation of 'evidence-based medicine'
Eriksson M; Angelin B; Sjöberg S
Letter: DIABETOLOGIA. 2002;45(7):1043-1044
Autonomic neuropathy is associated with impaired pancreatic polypeptide and neuropeptide Y responses to insulin-induced hypoglycaemia in Type I diabetic patients
Bolinder J; Sjöberg S; Persson A; Ahrén B; Sundkvist G
Review: LAKARTIDNINGEN. 1999;96(5):464-465
[Increased level of TSH can be a sign of adrenal cortex failure. Not necessarily thyroid gland disease].
Sjöberg S; Werner S
Book chapter: CANCER NEUTRON CAPTURE THERAPY. 1996;p. 131-136
Asymmetric Synthesis of o- and p-Carboranyl Amino Acids
Malmquist J; Carlsson J; Markides KE; Pettersson P; Olsson P; Sunnerheim-Sjöberg K; Sjöberg S
Book chapter: CANCER NEUTRON CAPTURE THERAPY. 1996;p. 49-56
Boron Neutron Capture Therapy Against Tumor Cells with Overexpression of the EGF-Receptor
Carlsson J; Gedda L; Grönvik C; Hartman T; Lindström A; Lundqvist H; Lövqvist A; Malmqvist J; Olsson P; Pontén J; Sjöberg S; Sjöström A; Stenerlöw B; Tilly N; Essand M; Tjarks W; Westermark B
Conference publication: DIABETOLOGIA. 1988;31(7):A543
ABNORMALITIES IN THE BINDING OF CIRCULATING INSULIN-LIKE GROWTH FACTOR-I TO THE CARRIER PROTEINS IN PROLIFERATIVE DIABETIC-RETINOPATHY
SJOBERG S; ARNER P; SKOTTNER A; GJOTTERBERG M
Conference publication: ACTA ENDOCRINOLOGICA. 1987;115:51
AN ASSOCIATION BETWEEN EARLY MICROANGIOPATHIC LESIONS, LACK OF INSULIN-SECRETION AND HLA DR 3/4, 3/X, 4/X PHENOTYPES IN LONG-TERM TYPE-1 DIABETES-MELLITUS
SJOBERG S; MOLLER E; OSTMAN J
Conference publication: ACTA ENDOCRINOLOGICA. 1985;110:91
RESIDUAL INSULIN PRODUCTION IN LONG-TERM TYPE-I DIABETES IS NOT RELATED TO MORE FAVORABLE LIPOPROTEIN PROFILES
SJOBERG S; GUNNARSSON R; ROSSNER S; OSTMAN J

Employments

Affiliated to Research, Department of Medicine, Huddinge, Karolinska Institutet, 2023-2025

Degrees and Education

Docent, Karolinska Institutet, 2001

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI